Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |
mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.0052 | 0.9 |